TheEdgeResearch
Home / Stocks / TSND.TO

TerrAscend Corp. (TSND.TO)

TSX Healthcare Drug Manufacturers - Specialty & Generic
$0.79 ▼ -2.47%
Market Cap
$244.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
2.02
52-Wk Range
0.53-2
CEO
Ziad Ghanem
Country
CA
Currency
CAD

TerrAscend Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Mississauga, ON, CA. The stock last traded at $0.79, down 2.47% on the session, giving a market capitalisation of $244.2M. Its beta of 2.02 implies it has historically moved more than the broad market.

Company profile
Exchange
Toronto Stock Exchange
Employees
933
IPO date
2017-05-03
Headquarters
Mississauga, ON, CA
About TerrAscend Corp.

TerrAscend Corp. operates as a comprehensive cannabis enterprise, engaging in the cultivation, processing, and distribution of cannabis products for both medical and regulated adult recreational markets across Canada and the United States. In addition to its core cannabis operations, the firm also develops and supplies hemp-derived wellness items to retail outlets and crafts specialty cannabis-infused edibles. It further expands its market presence by managing a network of retail dispensaries under The Apothecarium brand name in California, Pennsylvania, and New Jersey. The company's portfolio encompasses various integrated businesses and brands, including Gage Growth, Pinnacle, Ilera Healthcare, Valhalla Confections, State Flower, and Arise Bioscience Inc., among others. Established in 2017, TerrAscend maintains its corporate headquarters in Mississauga, Canada.

Comparable companies

TerrAscend Corp. is most often compared with the following Healthcare names:

ACB.TOCPH.TODR.TOEPRX.TOFRX.TOHLS.TOJUSH.CNOGI.TOWEED.TOXLY.TO
More research on TSND.TO
TSND.TO technical analysis TSND.TO TheEdge Score Compare against peers
Open full interactive analysis & DCF →